Immuno-Biological Laboratories Co Ltd
TSE:4570
Immuno-Biological Laboratories Co Ltd
TSE:4570
Price:
506 JPY
0.4%
Market Closed
Updated:
May 21, 2024
P/E
Price to Earnings
Price to Earnings
-24.5
Current
-16.1
Median
30.1
Industry
Lower
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-24.5
Market Cap
/
4.7B
Net Income
-192.7m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| JP |
|
Immuno-Biological Laboratories Co Ltd
TSE:4570
|
4.7B JPY | -24.5 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
224.7B USD | 37.3 | |
| US |
|
Danaher Corp
NYSE:DHR
|
197.4B USD | 24.5 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
45.3B USD | 36.4 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.5B USD | 30.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
55.4T KRW | 64.6 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37B CHF | 56.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
32.2B USD | 41.3 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
26.2B USD | 38.5 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
24.7B USD | 43.8 | |
| US |
|
Waters Corp
NYSE:WAT
|
20.8B USD | 34.6 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
N/A
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A
You don't have any saved screeners yet
